Table 1.
Summary of 283 patient characteristics in this present study
| Variables | Number (percentage) |
|---|---|
| Age: median [range] | 67 [18–89] |
| Gender | |
| Male | 238 (84%) |
| Female | 45 (16%) |
| ECOG performance status | |
| 0 | 223 (79%) |
| 1 | 60 (21%) |
| Primary disease | |
| Hypopharyngeal cancer | 97 (34%) |
| Oropharyngeal cancer | 91 (32%) |
| Laryngeal cancer | 46 (16%) |
| Nasopharyngeal cancer | 26 (9%) |
| Nasal and paranasal sinus cancer | 15 (5%) |
| Others | 8 (3%) |
| Clinical stage | |
| Early stage (I–II) | 134 (47%) |
| Advanced stage (≥ III) | 149 (53%) |
| Chemotherapy | |
| No | 97 (34%) |
| Yes | 186 (66%) |